ImStar Therapeutics

ImStar Therapeutics

ImStar Therapeutics

Developing promising new treatments for Amyotrophic Lateral Sclerosis (ALS) and neurodegenerative diseases
Founded
2012
Raised
$1.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Team Size
1–10
Employees
$1,800,000 Seed fund
PE Hub , BetaKit

Accel-Rx, BDC Capital lead $1.8 mln funding of ImStar Therapeutics